Podcast Link: https://www.youtube.com/watch?v=o4s4jfrRyvk

Patients in the US are spending nearly $500 billion a year on prescription drugs. Many still can't reliably get them.In this episode, Ankur Jain sits down with Gregory Leighton — founder of Status70 and a veteran of specialty pharmacy, patient services, and access management — to diagnose why the system keeps failing patients at the point of fulfillment, and what AI is getting wrong when it tries to fix it.They go deep on the 20-pharmacy problem, the $500B fragmented drug access market, what "best-in-class" actually means when 20 stakeholders all define it differently, and what the industry has to build to actually move the needle for patients.━━━━━━━━━━━━━━━━━━━━━━━━━━━━━👤 GUESTGregory Leighton — Founder, Status70Status70 builds intelligence infrastructure for specialty pharmacy and patient access.🔗 status70.com | linkedin.com/in/gregoryleighton👤 HOSTAnkur Jain — Founder, Artha ConsultingHealthcare AI transformation advisor. Helping health systems and pharma leadership move from AI pilots to scaled, measurable change.🔗 arthaconsultinglab.com | linkedin.com/in/ankurjaincons

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thehubbrief.substack.com